The examine, partly funded by the complement maker, discovered a mix of oral remedy with DHA and citicoline considerably improved visible capability and fee of development in sufferers with glaucoma after three months of remedy.
NI Award Judges praised the analysis for highlighting an space of well being that has not been broadly investigated. In addition they famous the strong methodology that includes a randomized management trial with a robust pattern, in addition to the spectacular final result.
“We’re so pleased to obtain this honor,” mentioned BrudyLab’s medical director Leia Garrotte, following the awards ceremony in Geneva on Might 15. “It was our first time at this contest, and the group was completely wonderful. Our workforce is thrilled with the chance to share this award and the great outcomes of the examine.”
Antioxidant properties
Glaucoma is a progressive optic neuropathy that impacts 57.5 million people around the world. It’s the second-leading reason behind blindness after cataracts. This blindness is normally irreversible.
The examine authors famous that many sufferers with glaucoma are really helpful to take nutraceuticals containing nutritional vitamins, citicoline or ginkgo biloba, amongst others, in medical apply.
Citicoline is an indispensable middleman within the synthesis of cell membrane phospholipids and a potential neuroprotectant or neuromodulator. In some international locations it’s used to facilitate restoration from stroke lesions or to deal with neurodegenerative ailments. In the meantime, DHA is an omega-3 polyunsaturated fatty acid with widely-demonstrated antioxidant properties.
